Current role of PET in oncology: Potentials and challenges in the management of non-small cell lung cancer

Phaneendra K. Yalavarthy, Daniel Low, Camille Noel, Zhouping Wei, Deshan Yang, Aditya Apte, Jeffrey Bradley, Joseph Deasy, Issam El Naqa

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

1 Scopus citations

Abstract

Recent years have witnessed rapid increase in positron emission tomography (PET) use for diagnosis, staging and restaging of different cancers types. A recent national review concluded that PET scans were associated with changing treatment plans in more than one third of the patients. For instance, FDG-PET, a glucose metabolism analog, is frequently used for radiotherapy target definition and monitoring of treatment response. However, its role in lung cancer, one of the most lethal diseases, is limited by respiratory motion artifacts. In this work, we summarize the latest developments to mitigate these effects and present potentials for future directions.

Original languageEnglish
Title of host publication2008 42nd Asilomar Conference on Signals, Systems and Computers, ASILOMAR 2008
Pages1067-1071
Number of pages5
DOIs
StatePublished - 2008
Event2008 42nd Asilomar Conference on Signals, Systems and Computers, ASILOMAR 2008 - Pacific Grove, CA, United States
Duration: Oct 26 2008Oct 29 2008

Publication series

NameConference Record - Asilomar Conference on Signals, Systems and Computers
ISSN (Print)1058-6393

Conference

Conference2008 42nd Asilomar Conference on Signals, Systems and Computers, ASILOMAR 2008
Country/TerritoryUnited States
CityPacific Grove, CA
Period10/26/0810/29/08

Keywords

  • Biomedical applications of radiation
  • Biomedical nuclear imaging
  • Medical diagnosis
  • Positron emission tomography

Fingerprint

Dive into the research topics of 'Current role of PET in oncology: Potentials and challenges in the management of non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this